Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Uterine fibroids Stories

2012-12-18 08:27:42

LONDON, Dec. 18, 2012 /PRNewswire/ -- Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today introduced the newest addition to its innovative TRUCLEAR(TM) System, the TRUCLEAR ULTRA Reciprocating Morcellator 4.0. Designed specifically for removing uterine fibroids, a health issue that will impact an estimated 80% of women(i), this new device provides surgeons with a fast, efficient solution for a hysteroscopic procedure that can help patients avoid the...

2012-10-31 15:25:31

SAN DIEGO, Oct. 31, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter and nine months ended September 30, 2012. For the third quarter of 2012, the Company reported a net loss of $3.1 million, or $0.05 loss per share, compared to net income of $31.4 million, or income of $0.56 per fully diluted share outstanding, for the same period in 2011. For the nine months ended September 30, 2012, the Company reported a net loss of $4.5...

2012-08-10 02:48:45

Women with uterine fibroids larger than 10 cm have a new nonsurgical treatment choice —hormone acting drugs followed by uterine artery embolization, a new study shows. The new treatment option can replace hysterectomy, which leaves women infertile. The study, conducted at the Yonsei University College of Medicine in Seoul South Korea, included 40 women with 10 cm or larger uterine fibroids. Twelve of the women received gonadotropin-releasing hormone (GnRH) agonists to shrink their...

2012-08-03 23:00:50

Campaign launched to help find answers for single mother Danita Tate and keep her from battling alone. Desert Hot Springs, CA (PRWEB) August 03, 2012 Despite being told by her health care provider that nothing more can be done for her, Danita Tate of Desert Hot Springs is not content to lie on her couch waiting to die. Tate´s family recently shared her story through television station KESQ. Motivated by that story, Media Demographics is now launching a media and social networking...

2012-07-31 10:26:00

SAN DIEGO, July 31, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended June 30, 2012. For the second quarter of 2012, the Company reported a net loss of $0.5 million, or $0.01 loss per share, compared to net income of $2.0 million, or $0.04 per share, for the same period in 2011. For the six months ended June 30, 2012, the Company reported a net loss of $1.4 million, or $0.02 loss per share, as compared to net income of...

2012-07-24 06:26:51

NEW YORK, July 24, 2012 /PRNewswire/ -- A hysterectomy, the removal of a women's uterus, is the second most common surgery for women in the United States. Hysterectomies are performed for various reasons including cancer, fibroids, endometriosis, prolapse of the uterus, chronic pelvic pain or abnormal vaginal bleeding. Although incredibly common, hysterectomies are typically only performed when no alternative option remains. (Photo: http://photos.prnewswire.com/prnh/20120717/NY41829 ) When...

2012-06-06 02:25:22

LONDON, June 6, 2012 /PRNewswire/ -- Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, announces its TRUCLEAR 5.0 System, the smallest hysteroscopic morcellator system(1) to receive 510(k) clearance from the FDA, is now available to US surgeons nationwide. With an outer diameter of only 5.0 mm, this patient-friendly instrumentation allows surgeons to safely and thoroughly remove intrauterine polyps and uterine fibroids under continuous visualization. While the...

2012-06-05 02:28:04

ABBOTT PARK, Ill., June 5, 2012 /PRNewswire/ -- Abbott (NYSE: ABT), in cooperation with Neurocrine Biosciences, Inc. (NASDAQ: NBIX), today announced the initiation of a pivotal Phase 3 clinical trial designed to evaluate the safety and efficacy of elagolix in female patients with endometriosis. Elagolix is an oral gonadotropin-releasing hormone (GnRH) antagonist. "Endometriosis can be a debilitating disease that affects millions of women around the world and the exploration of new...

2012-04-02 06:27:31

ATLANTA, April 2, 2012 /PRNewswire/ -- Infertility affects one in eight couples or 7.3 million people in the U.S. 12% of women of reproductive age experience difficulty having a baby and black women have twice the odds of infertility compared to white women. 11.5% of black women report infertility compared to 7% of white women but yet studies indicate that black women use infertility services less often. Why? "In the past, there was a lack of attention toward the problem of infertility in...

2012-03-12 07:00:00

Halt Medical, Inc. announced that it has closed on the first $20 million of a planned $50 million debt and equity financing. Livermore, CA (PRWEB) March 12, 2012 Halt Medical, Inc. announced that it has closed on the first $20 million of a planned $50 million debt and equity financing. “Leading the financing with the first $20 million is our long term investment partner American Capital Strategies (ACAS). American Capital´s financial resources, global perspective and life...